Original Research
Published on 30 Aug 2024
Ouabain-mediated downregulation of ALKBH5 and IGF2BP2 inhibits the malignant progression of DLBCL
in Pharmacology of Anti-Cancer Drugs
- 3,588 views
- 1 citation
Original Research
Published on 30 Aug 2024
in Pharmacology of Anti-Cancer Drugs
Review
Published on 16 Feb 2016
in Cellular Endocrinology
Review
Published on 17 Oct 2022
in Ethnopharmacology
Review
Published on 24 Mar 2025
in Pharmacology of Ion Channels and Channelopathies
Brief Research Report
Published on 19 Aug 2020
in Experimental Pharmacology and Drug Discovery
Review
Published on 02 Jun 2022
in Cardiovascular and Smooth Muscle Pharmacology
Review
Published on 25 May 2016
in Membrane Physiology and Membrane Biophysics
Original Research
Published on 10 Jun 2021
in Ethnopharmacology
Mini Review
Published on 07 Nov 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 11 Dec 2025
in Pharmacology of Ion Channels and Channelopathies
Mini Review
Published on 10 Nov 2017
in Integrative Physiology
Review
Published on 29 Jul 2025
in Pharmacology of Ion Channels and Channelopathies
Review
Published on 17 Jul 2014
in Neuroendocrine Science
Mini Review
Published on 31 Jan 2022
in Inflammation Pharmacology
Systematic Review
Published on 29 Aug 2022
in Neuropharmacology
Review
Published on 28 Jun 2016
in Membrane Physiology and Membrane Biophysics